The Arg719 residue at the C-terminal end of the stem region in hepatitis C virus JFH-1 E2 glycoprotein promotes viral infection

Virus Research

Volumn 172, Issue 1-2, 2013, Pages 1-8

  Qin, Zhao ling ^a   Ju, He peng ^a   Wang, Wen bo ^a   Ren, Hao ^a   Guan, Mo ^a   Zhao, Ping ^a   Qi, Zhong tian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Arginine; Envelope protein; Hepatitis C virus; Infection; Lysine; Stem region

Indexed keywords

ARGININE; CORE PROTEIN; GLYCOPROTEIN E2; LYSINE; VIRUS RNA;

AMINO ACID COMPOSITION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CULTURE; CONTROLLED STUDY; ELECTROPORATION; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA REPLICATION; VIROGENESIS; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN;

AMINO ACID SUBSTITUTION; ARGININE; CELL LINE; HEPACIVIRUS; HEPATOCYTES; HUMANS; MUTAGENESIS, SITE-DIRECTED; MUTANT PROTEINS; RNA, VIRAL; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS; VIRULENCE FACTORS; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 84873748203     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2012.11.010     Document Type: Article

References (34)

1. Albecka A., Montserret R., Krey T., Tarr A.W., Diesis E., Ball J.K., Descamps V., Duverlie G., Rey F., Penin F., Dubuisson J. Identification of new functional regions in hepatitis C virus envelope glycoprotein E2. Journal of Virology 2011, 85:1777-1792.
2. Alsaleh K., Delavalle P.Y., Pillez A., Duverlie G., Descamps V., Rouillé Y., Dubuisson J., Wychowski C. Identification of basic amino acids at the N-terminal end of the core protein crucial for HCV infectivity. Journal of Virology 2010, 84:12515-12528.
3. Brohm C., Steinmann E., Friesland M., Lorenz I.C., Patel A., Penin F., Bartenschlager R., Pietschmann T. Characterization of determinants important for hepatitis C virus p7 function in morphogenesis by using trans-complementation. Journal of Virology 2009, 83:11682-11693.
4. Cocquerel L., Op de Beeck A., Lambot M., Roussel J., Delgrange D., Pillez A., Wychowski C., Penin F., Dubuisson J. Topological changes in the transmembrane domains of hepatitis C virus envelope glycoproteins. The EMBO Journal 2002, 21:2893-2902.
5. Drummer H.E., Poumbourios P. Hepatitis C virus glycoprotein E2 contains a membrane-proximal heptad repeat sequence that is essential for E1E2 glycoprotein heterodimerization and viral entry. The Journal of Biological Chemistry 2004, 279:30066-30072.
6. Guidotti L.G., Chisari F.V. Immunobiology and pathogenesis of viral hepatitis. Annual Review of Pathology 2006, 1:23-61.
7. Hadlock K.G., Lanford R.E., Perkins S., Rowe J., Yang Q., Levy S., Pileri P., Abrignani S., Foung S.K. Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes. Journal of Virology 2000, 74:10407-10416.
8. Helle F., Vieyres G., Elkrief L., Popescu C.I., Wychowski C., Descamps V., Castelain S., Roingeard P., Duverlie G., Dubuisson J. Role of N-linked glycans in the functions of hepatitis C virus envelope proteins incorporated into infectious virions. Journal of Virology 2010, 84:11905-11915.
9. Kato T., Date T., Murayama A., Morikawa K., Akazawa D., Wakita T. Cell culture and infection system for hepatitis C virus. Nature Protocols 2006, 1:2334-2339.
10. Kato T., Date T., Miyamoto M., Furusaka A., Tokushige K., Mizokami M., Wakita T. Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon. Gastroenterology 2003, 125:1808-1817.
11. Kielian M. Class II virus membrane fusion proteins. Virology 2006, 344:38-47.
12. Kielian M., Rey F.A. Virus membrane-fusion proteins: more than one way to make a hairpin. Nature Reviews Microbiology 2006, 4:67-76.
13. Krey T., d'Alayer J., Kikuti C.M., Saulnier A., Damier-Piolle L., Petitpas I., Johansson D.X., Tawar R.G., Baron B., England P., Persson M.A., Martin A., Rey F.A. The disulfide bonds in glycoprotein e2 of hepatitis C virus reveal the tertiary organization of the molecule. PLoS Pathogens 2010, 6:e1000762.
14. Lescar J., Roussel A., Wien M.W., Navaza J., Fuller S.D., Wengler G., Wengler G., Rey F.A. The Fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH. Cell 2001, 105:137-148.
15. Lindenbach B.D., Rice C.M. Flaviviridae: the viruses and their replication. Fields Virology 2001, vol. 1:991-1041. Lippincott-Raven, Philadelphia. 4th ed.
16. Lindenbach B.D., Evans M.J., Syder A.J., Wölk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., Rice C.M. Complete replication of hepatitis C virus in cell culture. Science 2005, 309:623-626.
17. Moradpour D., Penin F., Rice C.M. Replication of hepatitis C virus. Nature Reviews Microbiology 2007, 5:453-463.
18. Mukhopadhyay S., Kuhn R.J., Rossmann M.G. A structural perspective of the flavivirus life cycle. Nature Reviews Microbiology 2005, 3:13-22.
19. Op De Beeck A., Montserret R., Duvet S., Cocquerel L., Cacan R., Barberot B., Le Maire M., Penin F., Dubuisson J. The transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerization. The Journal of Biological Chemistry 2000, 257:31428-31437.
20. Op De Beeck A., Voisset C., Bartosch B., Ciczora Y., Cocquerel L., Keck Z., Foung S., Cosset F.L., Dubuisson J. Characterization of functional hepatitis C virus envelope glycoproteins. Journal of Virology 2004, 78:2994-3002.
21. Penin F., Dubuisson J., Rey F.A., Moradpour D., Pawlotsky J.M. Structural biology of hepatitis C virus. Hepatology 2004, 39:5-19.
22. Qin Z.L., Zhao P., Cao M.M., Qi Z.T. siRNAs targeting terminal sequences of the SARS-associated coronavirus membrane gene inhibit M protein expression through degradation of M mRNA. Journal of Virological Methods 2007, 145:146-154.
23. Qin Z.L., Zhao P., Zhang X.L., Yu J.G., Cao M.M., Zhao L.J., Luan J., Qi Z.T. Silencing of SARS-CoV spike gene by small interfering RNA in HEK 293T cells. Biochemical and Biophysical Research Communications 2004, 324:1186-1193.
24. Rocha-Perugini V., Lavie M., Delgrange D., Canton J., Pillez A., Potel J., Lecoeur C., Rubinstein E., Dubuisson J., Wychowski C., Cocquerel L. The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry. BMC Microbiology 2009, 9:111.
25. Russell R.S., Meunier J.C., Takikawa S., Faulk K., Engle R.E., Bukh J., Purcell R.H., Emerson S.U. Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:4370-4375.
26. Shepard C.W., Finelli L., Alter M.J. Global epidemiology of hepatitis C virus infection. The Lancet Infectious Diseases 2005, 5:558-567.
27. Stiasny K., Heinz F.X. Flavivirus membrane fusion. The Journal of General Virology 2006, 87:2755-2766.
28. Tong Y., Zhu Y., Xia X., Liu Y., Feng Y., Hua X., Chen Z., Ding H., Gao L., Wang Y., Feitelson M.A., Zhao P., Qi Z.T. Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection. Journal of Virology 2011, 85:2793-2802.
29. Vieyres G., Thomas X., Descamps V., Duverlie G., Patel A.H., Dubuisson J. Characterization of the envelope glycoproteins associated with infectious hepatitis C virus. Journal of Virology 2010, 84:10159-10168.
30. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Kräusslich H.G., Mizokami M., Bartenschlager R., Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nature Medicine 2005, 11:791-796.
31. Whidby J., Mateu G., Scarborough H., Demeler B., Grakoui A., Marcotrigiano J. Blocking hepatitis C virus infection with a recombinant form of envelope protein 2 ectodomain. Journal of Virology 2009, 83:11078-11089.
32. Yi M., Ma Y., Yates J., Lemon S.M. Compensatory mutations in E1, p7, NS2, and NS3 enhance yields of cell culture-infectious intergenotypic chimeric hepatitis C virus. Journal of Virology 2007, 81:629-638.
33. Zhong J., Gastaminza P., Cheng G., Kapadia S., Kato T., Burton D.R., Wieland S.F., Uprichard S.L., Wakita T., Chisari F.V. Robust hepatitis C virus infection in vitro. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:9294-9299.
34. Zhong J., Gastaminza P., Chung J., Stamataki Z., Isogawa M., Cheng G., McKeating J.A., Chisari F.V. Persistent hepatitis C virus infection in vitro: coevolution of virus and host. Journal of Virology 2006, 80:11082-11093.